Author name: TB Alliance

Over the last few months, the TB Alliance advanced plans to enlist the R&D capacity of endemic countries. By consulting

Tuberculosis is a crafty foe. About 2 billion people are infected worldwide, but most show no symptoms, remaining disease-free for

In the United States, President Bush pledged $15 billion to fight the ongoing devastation caused by AIDS in Africa and

The TB Alliance opened 2003 with an expanded portfolio of drug candidates and projects. A number of projects are now

Drug company sees funding research to combat dengue and tuberculosis as corporate goodwill–and good business Singapore–Swiss drug giant Novartis is

Novartis AG has launched its Novartis Institute for Tropical Diseases (NITD) in Singapore with a two-day symposium. Dr. Paul Herrling,

TROPICAL fevers often leave their victims running hot and cold. Critics of the pharmaceutical industry argue that drugmakers behave in

The Alliance is convening a core group of leading scientists after this week’s Keystone meeting on TB Genomics to assess